Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2016 (2016), Article ID 5134732, 12 pages
http://dx.doi.org/10.1155/2016/5134732
Research Article

Molecular Modeling Studies of Some Uracil and New Deoxyuridine Derivatives

1Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmacy, Future University in Egypt, 90th Street, New Cairo, Egypt
2Computational Chemistry Unit, Department of Chemistry, Faculty of Science, Ain Shams University, Abbassia, Cairo 11566, Egypt

Received 3 June 2016; Accepted 25 July 2016

Academic Editor: Adrienn Ruzsinszky

Copyright © 2016 Yousra Abdel-Mottaleb and M. S. A. Abdel-Mottaleb. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Shah, E. Nosheen, F. Zafar et al., “Photochemistry and electrochemistry of anticancer uracils,” Journal of Photochemistry and Photobiology B: Biology, vol. 117, pp. 269–277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C. H. Wu, C. C. Wu, and Y. S. Ho, “Antitumor activity of combination treatment of Lentinus edodes mycelium extracts with 5-fluorouracil against human colon cancer cells xenografted in nude mice,” Journal of Cancer Molecules, no. 3, pp. 15–22, 2007. View at Google Scholar
  3. D. J. Brown, Heterocyclic Compounds: Thy Pyrimidines, Interscience, New York, NY, USA, 52nd edition, 1994.
  4. A. F. Pozharskii, A. T. Soldatenkov, and A. R. Katrizky, Heterocycles in Life and Society, John Wiley & Sons, New York, NY, USA, 1997.
  5. D. De Berker, J. M. McGregor, and B. R. Hughes, “Guidelines for the management of actinic keratoses,” British Journal of Dermatology, vol. 156, no. 2, pp. 222–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Ardalan, R. Luis, M. Jaime, and D. Franceschi, “Biomodulation of fluorouracil in colorectal cancer,” Cancer Investigation, vol. 16, no. 4, pp. 237–251, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Freelove and A. D. Walling, “Pancreatic cancer: diagnosis and management,” American Family Physician, vol. 73, no. 3, pp. 485–492, 2006. View at Google Scholar · View at Scopus
  8. J. A. Saonere, “Awareness screening programme reduces the risk of cervical cancer in women,” African Journal of Pharmacy and Pharmacology, vol. 4, no. 6, pp. 314–323, 2010. View at Google Scholar · View at Scopus
  9. E. J. Choi and G.-H. Kim, “5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells,” Oncology Reports, vol. 22, no. 6, pp. 1533–1537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. B. Longley, D. P. Harkin, and P. G. Johnston, “5-Fluorouracil: mechanisms of action and clinical strategies,” Nature Reviews Cancer, vol. 3, no. 5, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Pałasz and D. Cież, “In search of uracil derivatives as bioactive agents. Uracils and fused uracils: synthesis, biological activity and applications,” European Journal of Medicinal Chemistry, vol. 97, pp. 582–611, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. N. F. Smith, W. D. Figg, and A. Sparreboom, “Recent advances in pharmacogenetic approaches to anticancer drug development,” Drug Development Research, vol. 62, no. 3, pp. 233–253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Heildelberger, P. V. Dannenberg, and R. G. Moran, Advances in Enzymology and Related Areas of Molecular Biology, Edited by A. Meister, John Wiley & Sons, New York, NY, USA, 1983.
  14. L. W. Hardy, J. S. Finer-Moore, W. R. Montfort, M. O. Jones, D. V. Santi, and R. M. Stroud, “Atomic structure of thymidylate synthase: target for rational drug design,” Science, vol. 235, no. 4787, pp. 448–455, 1987. View at Publisher · View at Google Scholar · View at Scopus
  15. B. K. Shoichet, R. M. Stroud, D. V. Santi, I. D. Kuntz, and K. M. Perry, “Structure-based discovery of inhibitors of thymidylate synthase,” Science, vol. 259, no. 5100, pp. 1445–1450, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. G. L. Patrick, An Introduction to Medicinal Chemistry, Oxford University Press, Oxford, UK, 5th edition, 2013.
  17. M. V. Putz and N. A. Dudaş, “Determining chemical reactivity driving biological activity from SMILES transformations: the bonding mechanism of anti-HIV pyrimidines,” Molecules, vol. 18, no. 8, pp. 9061–9116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Bruna-Larenas and J. S. Gómez-Jeria, “A DFT and semiempirical model-based study of opioid receptor affinity and selectivity in a group of molecules with a morphine structural core,” International Journal of Medicinal Chemistry, vol. 2012, Article ID 682495, 16 pages, 2012. View at Publisher · View at Google Scholar
  19. L. Kosychova, A. Karalius, Z. Staniulytė et al., “New 1-(3-nitrophenyl)-5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines: synthesis and computational study,” Molecules, vol. 20, no. 4, pp. 5392–5408, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Jeyavijayan, “Spectroscopic (FTIR, FT-Raman), molecular electrostatic potential, NBO and HOMO–LUMO analysis of P-bromobenzene sulfonyl chloride based on DFT calculations,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 136, pp. 890–899, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Roy, A. Bauza, R. Banik, S. C. Biswas, A. Frontera, and S. Das, “Structural basis for molecular recognition, theoretical studies and anti-bacterial properties of three bis-uracil derivatives,” Tetrahedron, vol. 70, no. 39, pp. 6931–6937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Frisch, G. W. Trucks, H. B. Schlegel et al., GAUSSIAN09, Revision D.01, Gaussian, Inc, Wallingford, Conn, USA, 2013.
  23. P. Politzer and J. S. Murray, “The fundamental nature and role of the electrostatic potential in atoms and molecules,” Theoretical Chemistry Accounts, vol. 108, no. 3, pp. 134–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Murray and P. Politzer, “The electrostatic potential: an overview,” Wiley Interdisciplinary Reviews: Computational Molecular Science, vol. 1, no. 2, pp. 153–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Geerlings, F. de Proft, and W. Langenaeker, “Conceptual density functional theory,” Chemical Reviews, vol. 103, no. 5, pp. 1793–1873, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Murray and K. Sen, Molecular Electrostatic Potentials, Concepts and Applications, Elsevier, Amsterdam, Netherlands, 1996.
  27. E. Scrocco and J. Tomasi, “Electronic molecular structure, reactivity and intermolecular forces: an euristic interpretation by means of electrostatic molecular potentials,” in Advances in Quantum Chemistry, P. Lowdin, Ed., vol. 11, pp. 115–193, Academic Press, New York, NY, USA, 1978. View at Publisher · View at Google Scholar
  28. T. Lukmanov, P. Sergey, M. Edward, and L. Sergey, “Relative stability of keto-enol tautomers in 5,6-substituted uracils: ab initio, DFT and PCM study,” in Computational and Theoretical Chemistry, vol. 102, pp. 38–45, 2013. View at Publisher · View at Google Scholar
  29. V. K. Rastogi and M. Alcolea Palafox, “Vibrational spectra, tautomerism and thermodynamics of anticarcinogenic drug: 5-Fluorouracil,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 79, no. 5, pp. 970–977, 2011. View at Publisher · View at Google Scholar · View at Scopus